CN1207010C - Liquid medicine for treating beriberi - Google Patents

Liquid medicine for treating beriberi Download PDF

Info

Publication number
CN1207010C
CN1207010C CN 00136574 CN00136574A CN1207010C CN 1207010 C CN1207010 C CN 1207010C CN 00136574 CN00136574 CN 00136574 CN 00136574 A CN00136574 A CN 00136574A CN 1207010 C CN1207010 C CN 1207010C
Authority
CN
China
Prior art keywords
present
hydrochloric acid
liquid medicine
treating beriberi
distilled water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 00136574
Other languages
Chinese (zh)
Other versions
CN1358521A (en
Inventor
杨幼仑
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 00136574 priority Critical patent/CN1207010C/en
Publication of CN1358521A publication Critical patent/CN1358521A/en
Application granted granted Critical
Publication of CN1207010C publication Critical patent/CN1207010C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses liquid medicine for treating beriberi, which is characterized in that the present invention has the following formula: 18% to 22% of diluted hydrochloric acid, 1% to 4.5% of native copper, 73% to 58% of distilled water, 3% to 7.5% of manchurian wildginger and 5% to 8% of indigo. Since the present invention adopts the ingredients, such as diluted hydrochloric acid, manchurian wildginger, native copper, etc., the present invention has the advantages of quick therapeutic effects, high cure rate, convenient usage, etc. The present invention does not have side effects or medicine resistance, and simultaneously, the cost of the present invention is low.

Description

Beriberi liquor
Technical field
The present invention relates to a kind of medicament, relate to a kind of beriberi liquor specifically.
Background technology
At present, the medicament of treatment beriberi commonly used generally has certain curative effect on the market, but general therapeutic process is long, takes effect slowly, treat not thorough, and its feedstock capture difficulty, cost is higher, in addition, such medicine mostly is paste, easily pollutes footgear.
Summary of the invention
Purpose of the present invention just is to provide a kind of treatment cycle short, and good effect is treated more thorough, with low cost beriberi liquor.
Purpose of the present invention can realize by following measure:
The present invention is formed by following feedstock production, by weight percentage: dilute hydrochloric acid 18%-22%, Pyritum 1%-4.5%, distilled water 73%-58%, Herba Asari 3%-7.5%, Indigo Naturalis 5%-8%.
The present invention makes the present invention have advantages such as curative effect is fast, cure rate is high, easy to use, and has no side effect and Drug resistance owing to adopt compositions such as dilute hydrochloric acid, Herba Asari, Pyritum, and simultaneously, its cost is also lower.
The specific embodiment
The present invention does with detailed description below in conjunction with embodiment:
Embodiment 1: the present invention is formed by following feedstock production, by weight percentage: dilute hydrochloric acid 20%, Pyritum 3%, distilled water 67%, Herba Asari 4%, Indigo Naturalis 6% gets final product the mentioned component mixed preparing.
Embodiment 2: the present invention is formed by following feedstock production, by weight percentage: dilute hydrochloric acid 19%, Pyritum 4%, distilled water 65%, Herba Asari 5%, Indigo Naturalis 7% gets final product the mentioned component mixed preparing.

Claims (1)

1, a kind of beriberi liquor is characterized in that: it is to be formed by following feedstock production, by weight percentage: dilute hydrochloric acid 18%-22%, Pyritum 1%-4.5%, distilled water 73%-58%, Herba Asari 3%-7.5%, Indigo Naturalis 5%-8%.
CN 00136574 2000-12-21 2000-12-21 Liquid medicine for treating beriberi Expired - Fee Related CN1207010C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 00136574 CN1207010C (en) 2000-12-21 2000-12-21 Liquid medicine for treating beriberi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 00136574 CN1207010C (en) 2000-12-21 2000-12-21 Liquid medicine for treating beriberi

Publications (2)

Publication Number Publication Date
CN1358521A CN1358521A (en) 2002-07-17
CN1207010C true CN1207010C (en) 2005-06-22

Family

ID=4597361

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 00136574 Expired - Fee Related CN1207010C (en) 2000-12-21 2000-12-21 Liquid medicine for treating beriberi

Country Status (1)

Country Link
CN (1) CN1207010C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109260272A (en) * 2018-11-26 2019-01-25 颜士玲 A kind of berberi powder

Also Published As

Publication number Publication date
CN1358521A (en) 2002-07-17

Similar Documents

Publication Publication Date Title
PT1670444E (en) Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
CN101991521A (en) Tea tree oil mouth wash and preparation method thereof
CN105662977A (en) Agilawood healthcare toothpaste and preparation method thereof
CN103239372A (en) Mild moisturizing mask liquid and preparation method thereof
CN101062142A (en) Almond pill for smoothing intestines
CN1207010C (en) Liquid medicine for treating beriberi
CN103239731B (en) Edible buccal patch for treating dental ulcer
CN1225243C (en) Fluid for dispelling prickly heat and dermatitis and preparation method
CN102631406A (en) Mouthwash for oral ulcer
CN111888406A (en) Chinese medicine preparation widely used for epidermic inflammation and preparation method thereof
CN1084185C (en) Liquid spray for treating oral and throat diseases and its preparing process
CN101204470B (en) Application of grape fermented product on skin sterilization and health protection products filed
CN1327827A (en) Exterior-applied medicine for treating dermatopathy
CN110801458A (en) Preparation method of onychomycosis liquid
CN105343097A (en) Composition containing caffeine and application and manufacturing method of composition containing caffeine
CN101444473A (en) Foot softening cream
CN117562956A (en) Mild sterilization type alcohol-containing washing-free disinfection gel and preparation method thereof
CN103690599A (en) Dental ulcer ointment containing marine biological ingredients
CN110448597A (en) A kind of golden aster acne cream
CN105878332A (en) Traditional Chinese medicine ointment for treating onychomycosis
CN110420172A (en) A kind of unguentum acidi salicylici for treating corn
CN103655303A (en) Macula-removing beauty fluid containing marine biological ingredients and preparation method thereof
CN117860587A (en) Liquid dressing, preparation method and application
CN1552843A (en) Lanqi vinegar
CN113712877A (en) Nicotinamide chamomile skin-beautifying mask liquid and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee